Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1671 1687
This examiner grants 29% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17162897 | SIGNIFICANCE MODELING OF CLONAL-LEVEL ABSENCE OF TARGET VARIANTS | Non-Final OA | GUARDANT HEALTH, INC. |
| 16560752 | METHODS AND SYSTEMS FOR DETECTING ALLELIC IMBALANCE IN CELL-FREE NUCLEIC ACID SAMPLES | Non-Final OA | GUARDANT HEALTH, INC. |
| 18243623 | HEALTH-RELATED SIGNALING VIA WEARABLE ITEMS | Non-Final OA | Biolinq Incorporated |
| 16827366 | HEALTH-RELATED SIGNALING VIA WEARABLE ITEMS | Non-Final OA | Biolinq Incorporated |
| 17669258 | METHOD FOR CORRECTING DATA RELATED TO ELECTROPHORESIS, METHOD FOR DETERMINING WHETHER PEAK IS SAMPLE-DERIVED PEAK OR SPIKE, APPARATUS, AND PROGRAM | Final Rejection | HITACHI, LTD. |
| 16816732 | BIOLOGICAL REACTION INFORMATION PROCESSING SYSTEM AND BIOLOGICAL REACTION INFORMATION PROCESSING METHOD | Non-Final OA | Hitachi, Ltd. |
| 19226403 | METHOD FOR GENERATION OF CHEMICAL DERIVATIVES AGAINST TARGET PROTEIN TO BUILD AI DRUG PLATFORM | Final Rejection | SYNTEKABIO, INC. |
| 19219826 | ASSESSING RISK FOR MULTIPLE MYELOMA PRECURSOR DISEASE PROGRESSION | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 19098448 | IDENTIFICATION OF SOMATIC OR GERMLINE ORIGIN FOR CELL-FREE DNA | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17436817 | DATA ANALYSIS METHOD, DATA ANALYSIS SYSTEM, AND COMPUTER | Final Rejection | HITACHI HIGH-TECH CORPORATION |
| 17636272 | SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION | Non-Final OA | The General Hospital Corporation |
| 17711617 | GENERATING MINORITY-CLASS EXAMPLES FOR TRAINING DATA | Non-Final OA | NEC Laboratories America, Inc. |
| 17221430 | SYSTEM AND METHOD FOR GENERATING A TOXICOLOGICAL AILMENT NOURISHMENT PROGRAM | Non-Final OA | KPN INNOVATIONS, LLC. |
| 17766008 | PROCESS AND DEVICE FOR DETERMINING A RESPIRATORY AND/OR CARDIOGENIC SIGNAL | Non-Final OA | Drägerwerk AG & Co. KGaA |
| 16417336 | INFERRING SELECTION IN WHITE BLOOD CELL MATCHED CELL-FREE DNA VARIANTS AND/OR IN RNA VARIANTS | Final Rejection | Grail, LLC |
| 17632658 | SYSTEMS AND METHODS FOR DISEASE AND TRAIT PREDICTION THROUGH GENOMIC ANALYSIS | Non-Final OA | SALK INSTITUTE FOR BIOLOGICAL STUDIES |
| 17585358 | ECG SEARCH AND INTERPRETATION BASED ON A DUAL ECG AND TEXT EMBEDDING MODEL | Final Rejection | AliveCor, Inc. |
| 16612647 | METHODS AND SYSTEMS FOR ASSESSING THE PRESENCE OF ALLELIC DROPOUT USING MACHINE LEARNING ALGORITHMS | Non-Final OA | SYRACUSE UNIVERSITY |
| 17777100 | METHOD FOR DETECTING LUNG CANCER | Non-Final OA | Sierra Medical Ltd |
| 17555968 | METHOD AND SYSTEM FOR OBTAINING, CONTROLLING, ACCESSING AND/OR DISPLAYING PERSONAL GENETIC IDENTIFICATION INFORMATION | Final Rejection | STR-ID, INC. |
| 17207485 | PREDICTING EFFICACY OF PREVENTATIVE MEASURES TO MITIGATE SPREAD OF A PATHOGEN AND ILLNESSES CAUSED THEREFROM USING MACHINE LEARNING MODELS | Final Rejection | General Genomics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy